MyFinsight
Home
Blog
About
Contact
espr: the balance sheet
Download
Download image
Other prepaid and
current assets
$4,408K
Prepaid inventory costs
$33,299K
Prepaid clinical
development costs
$2,791K
Inventories, net
$108,539K
Accounts receivable, net
$118,980K
Cash and cash
equivalents
$92,447K
Intangible assets
$56K
Right of use operating
lease assets
$3,325K
Property and equipment,
net
$175K
Total current assets
$360,464K
Total assets
$364,020K
Accumulated deficit
-$1,685,542K
Treasury stock, at cost
1,994,198 shares at...
$54,998K
Total liabilities and
stockholders deficit
$364,020K
Total stockholders
deficit
-$451,361K
Additional paid-in capital
$1,288,974K
Common stock, 0.001 par
value 480,000,000...
$205K
Total liabilities
$815,381K
Other long-term
liabilities
$7,436K
Operating lease
liabilities
$767K
Long-term debt
$151,653K
Royalty sale liability
$199,364K
Convertible notes, net of
issuance costs
$97,128K
Total current
liabilities
$359,033K
Operating lease
liabilities
$2,384K
Deferred revenue from
collaborations
$30,679K
Royalty sale liability
$94,826K
Other accrued
liabilities
$18,641K
Accrued variable
consideration
$78,508K
Accrued clinical
development costs
$1,619K
Convertible notes, net of
issuance costs
$54,863K
Accounts payable
$77,513K
Back
Back
Balance Sheet
source: myfinsight.com
Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. (ESPR)